SOMAYA ABBOUD: Open Payments
NPI 1326089004 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 27 payments from 11 companies in 2025. Trend: 2023 $386 · 2024 $514 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $302 |
| Exact Sciences Corporation | 6 | $180 |
| Novo Nordisk Inc | 7 | $109 |
| La Jolla Pharmaceutical Company | 1 | $97 |
| Lilly USA, LLC | 2 | $32 |
| Smith+Nephew, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| ConvaTec Inc. | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
Products named: REPATHA, The Cologuard Plus Collection Kit, GIAPREZA, Cologuard Collection Kit, OTEZLA, Ozempic, Wegovy, COLLAGENASE SANTYL.
Industry payments across NJ — which companies pay providers there.
